Neil Woodford has returned 16 months after the collapse of Woodford Investment Management with the launch of a new investment firm, which is working alongside Acacia Research to "advise" on an illiquid and unlisted portfolio of life sciences companies once owned by the Woodford Equity Income fund (WEIF).
Woodford will serve as CIO of WCM Partners, which will be based in Buckinghamshire and Jersey, serving institutional and high-net-worth investors. Woodford investors potentially in limbo for further 12 months The Acacia life sciences assets were part of "Portfolio B" in the WEIF liquidation process, with a £223.9m agreement struck between the firm and specialist broker PJT Park Hill in June to package up 19 assets, including Theravance Biopharma and Oxford Nanopore. WCM said in a statement that the assets "will form the cornerstone of a new strategy to rebuild the Woodford investme...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
